30 C
Lucknow
July 24, 2024
The Hona News
health

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D



For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine.



Source link

Related posts

New study reveals dynamic impact of nicotine on brain regions responsible for reward and aversion

asdavi92

6 Gifts to Avoid as Per Vastu Shastra

asdavi92

Man gives Rs 2k to street vendor to pack food. See her reaction

asdavi92

Leave a Comment